1. Medtech Insight
  2. >>Business

Siemens Healthineers In Line With Future Trends As It Mines Workflow And Outcomes Seams

 
• By Ashley Yeo

Siemens Healthineers  ̶  an engineering company by background – sees itself well positioned to benefit from the markets’ movement towards digital, workflows, robotics and minimally-invasive procedures. As such, it has advantages over pharma companies in being able to deliver better patient outcomes at lower cost and more effectively.

MRI

Siemens Healthineers might be forgiven for congratulating itself on its track record and upwards trajectory in its three business segments less than two years after its March 2018 IPO and establishment as a stand-alone manufacturer. The €14.5bn ($16.2bn) revenues company retains the innovation-driven culture of the wider Siemens group, and shares its business code, but is now both more mobile and visible as a health-care player.

Addressing Jefferies Healthcare delegates, Healthineers’ CFO Jochen Schmitz said that that company has a very real and clear purpose, now...

More from Business

More from Medtech Insight

Ochsner Surgeon In ‘The Big Easy’ Eases Patient’s Pain With Skill And Virtual Reality

 
• By Brian Bossetta

A surgeon at Ochsner Health in New Orleans was able to successfully remove a rare and dangerous tumor from a patient’s spine using cutting-edge technology that would have otherwise made the procedure too risky.

Execs On The Move: June 30–July 4, 2025

 
• By Medtech Insight Team

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

FDA Commissioner’s Voucher Program Should Include Devices, Transplant Technology Firm Says

 
• By Elizabeth Orr

The FDA's new Commissioner’s National Priority Voucher program aims to expedite drug approvals significantly. Device firms like XVIVO advocate for a similar initiative for devices, emphasizing the potential for faster reviews and improved patient access to lifesaving technologies.